Emerging Credit Rating Limited (ECRL) has assigned BBB (Pronounced as Triple B) long term credit rating and ST-3 short term credit rating to Globex Pharmaceuticals Limited. The outlook of the rating is Stable. The rating is based on audited financial statement of FY2020-2023, bank information and other qualitative along with quantitative relevant information up to the date of rating.